A nurse is caring for a postoperative 70-kg patient who had major blood loss during surgery and now has acute kidney injury. The patient does not have signs of fluid overload. Which intervention would be most effective as a fluid challenge to promote kidney perfusion?

Choice A reason: Not needing vascular access to perform PD is a significant advantage for patients. Peritoneal dialysis uses the peritoneal membrane in the abdomen as a filter to clean the blood, which eliminates the need for vascular access, such as fistulas or catheters required in hemodialysis. This can reduce the risks associated with vascular access, such as infections and complications related to surgical procedures.

Choice B reason: Being able to perform PD in the comfort of one's home is a major benefit. Patients can manage their dialysis treatments at home, which offers more convenience and flexibility compared to traveling to a dialysis center for hemodialysis sessions. This can greatly improve the quality of life and reduce the burden of frequent trips to healthcare facilities.

Choice C reason: Stating that there is no risk for infection with PD is inaccurate. While PD offers many benefits, it does carry a risk of peritonitis, an infection of the peritoneal cavity. Patients must be educated on proper technique and hygiene to minimize this risk. Hence, this statement is not accurate and should not be included as an advantage.

Choice D reason: Having flexibility in when to do the exchanges is another benefit of PD. Patients can schedule their dialysis exchanges at times that best fit their lifestyle and daily routines. This flexibility allows for greater independence and freedom compared to the fixed schedules required for in-center hemodialysis.

Choice E reason: PD can take less time than hemodialysis treatments, especially when considering travel and waiting times associated with in-center hemodialysis. Although the actual dialysis process for PD requires regular exchanges throughout the day or night, it integrates more seamlessly into daily life, making it a time-efficient option for many patients.

Choice A reason: Warfarin is an anticoagulant commonly used in patients with atrial fibrillation to prevent the formation of blood clots. Atrial fibrillation increases the risk of stroke due to the potential for blood clots forming in the heart and traveling to the brain. Warfarin helps reduce this risk by thinning the blood and preventing clot formation.

Choice B reason: Atropine is used to treat bradycardia (slow heart rate) and is not typically used for patients with atrial fibrillation. Its primary function is to increase the heart rate by blocking the vagus nerve's effects on the heart. In the context of atrial fibrillation, anticoagulation is more crucial to prevent complications like stroke.

Choice C reason: Dobutamine is an inotropic agent used to increase cardiac output in patients with heart failure or cardiogenic shock. It is not used for managing atrial fibrillation. Dobutamine works by stimulating the heart to pump more effectively but does not address the risks associated with atrial fibrillation, such as blood clot formation.

Choice D reason: Magnesium sulfate is used to treat various conditions, including torsades de pointes (a type of abnormal heart rhythm) and severe asthma attacks. It is not typically used for atrial fibrillation. The focus in atrial fibrillation management is on controlling the heart rate or rhythm and preventing thromboembolic complications with anticoagulation therapy.